INVESTORS & MEDIA HOME More Download Mesoblast Corporate Overview - March 2020 Mesoblast Corporate Overview (2 MB) More Latest ASX Announcements 01 April 2020 FDA Accepts BLA for RYONCIL and Agrees to Priority Review 30 March 2020 Ischemic End Stage HF Outcomes at Virtual ACC Annual Meeting 20 March 2020 Change of Director's Interest Notice 17 March 2020 Appendix 2A More Upcoming Events There are currently no events scheduled. More Stock Quote Exchange : Price : Change : Volume : Data as of 03 April 2020 9:38 PM EDT Exchange : Price : Change : Volume : Data as of 03 April 2020 9:38 PM EDT Copyright West LLC. Minimum 15 minutes delayed. Financial Results for First Half Year Ended December 31, 2019 Presentation to 2019 Annual General Meeting First Quarter Results Presentation 2019 Annual Report E-mail Alerts Sign up here to receive e-mail alerts.
